Table 5.
Classification of Myocardial, Pericardial Disease Induced Brugada Phenocopies
Categories | First Author (Publish Year) | Descriptor of Condition | Age/Gender | EKG type | Structural Heart Disease | Note | Outcome |
---|---|---|---|---|---|---|---|
Acute myocarditis | Bramos (2009) 95 | Cardiac amyloidosis | 72/F | Type‐1 | Concentric hypertrophy | Narrow complex tachycardia was present | Normalization of ECG after 1 day |
Kim (2008) 96 | Hematologic disease leading to acute myocarditis | 42/M 46/M | Type‐1 Type‐1 &2 | Nonreported | Increase WBC count | Patient 1, ECG normalized after 2 months Patient 2 eventually died | |
Nayyar (2009) 97 | Myocarditis | 56/F | Type‐1 | Biventricular severe global systolic dysfunctions | Aluminum Phosphide Poisoning | Died on third day of admission from acute renal shutdown. | |
Chronic myocarditis | Brito (2010) 98 | Chagas disease cardiomyopathy | 56/F | Type‐1 & 2 | Nonreported | Syncope, palpitation, apical left ventricular aneurysm | Not reported |
Acute pericarditis | Ozeke (2006) 99 | Pericarditis | 28/M 36/M | Type‐2 | Nonreported | Both patients were afebrile, no prescription drug noted. | ECG normalized after treatment ibuprofen |
Myotonic dystrophy | Rudnik‐Schoneborn (2010) 100 | Myotonic dystrophy | 49/M | Type‐2 | Nonreported | Metformin, myotonic dystrophy confirmed by genetic testing | Not reported |
Descriptor = the primary condition that is believed to cause Brugada ECG pattern; M = male; F = female; Note = any medication taken or clinical condition that the patient presented; Outcome = resolution of Brugada ECG and patient mortality and morbidity, if available.